Alcohol

Alcohol

SCHEMBL2508797

CCO.O=[PH](O)O[PH](=O)O.[Na]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL8604617 1.00 ALDH1A1 (0.38) ALDH1A1TSHR
Alcohol SCHEMBL639197 1.00 ALDH1A1 (0.38) ALDH1A1TSHR
Alcohol SCHEMBL94631 0.97 ALDH1A1 (0.40) ALDH1A1TSHR
Alcohol SCHEMBL10862814 0.94 ALDH1A1 (0.38) ALDH1A1TSHR
Alcohol SCHEMBL10857495 0.94 ALDH1A1 (0.38) ALDH1A1TSHR
Propane SCHEMBL987968 0.87
Propanol SCHEMBL10860538 0.85 ALDH1A1 (0.33) ALDH1A1TSHR
Butane SCHEMBL27301811 0.84 ALDH1A1 (0.30) ALDH1A1
Ethane SCHEMBL10635720 0.83
SCHEMBL8928294 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624316-B2 Treatment composition with delivery particles made from acid-treated chitosan THE PROCTER & GAMBLE COMPANY (US) 2026-05-12 US disclosed
US-20260071153-A1 TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES ENCAPSYS, LLC (US) 2026-03-12 US disclosed
US-20250376643-A1 TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES ENCAPSYS, LLC (US) 2025-12-11 US disclosed
US-20250361461-A1 TREATMENT COMPOSITION WITH DUCTILE DELIVERY PARTICLES ENCAPSYS, LLC (US) 2025-11-27 US disclosed
US-20250325489-A1 DEGRADABLE DELIVERY PARTICLES FROM MIXED ACID TREATED CHITOSAN ENCAPSYS, LLC (US) 2025-10-23 US disclosed
US-20240182821-A1 TREATMENT COMPOSITION WITH PERFUME-CONTAINING DELIVERY PARTICLES THE PROCTER & GAMBLE COMPANY 2024-06-06 US disclosed
US-20240182820-A1 TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES THE PROCTER & GAMBLE COMPANY 2024-06-06 US disclosed
US-20240182816-A1 TREATMENT COMPOSITION THE PROCTER & GAMBLE COMPANY 2024-06-06 US disclosed
US-20240182823-A1 TREATMENT COMPOSITION WITH DELIVERY PARTICLES MADE FROM ACID-TREATED CHITOSAN THE PROCTER & GAMBLE COMPANY 2024-06-06 US disclosed
EP-4019000-A1 TREATMENT COMPOSITIONS COMPRISING CERTAIN PLANT ROSIN MATERIALS The Procter & Gamble Company (US) 2022-06-29 EP disclosed
EP-3662974-A1 COMPOSITIONS COMPRISING ENCAPSULATES The Procter & Gamble Company (US) 2020-06-10 EP disclosed
EP-2674477-B1 Cationic polymer stabilized microcapsule composition PROCTER & GAMBLE (US) 2018-09-12 EP disclosed
EP-2553080-B1 PROCESS FOR COATING CATIONIC POLYMERS ON MICROCAPSULES PROCTER & GAMBLE (US) 2017-08-23 EP disclosed
EP-2257667-B1 WASHER DRYER RHODIA OPERATIONS (FR) 2017-08-16 EP disclosed
US-8765659-B2 Cationic polymer stabilized microcapsule composition THE PROCTER & GAMBLE COMPANY (US) 2014-07-01 US disclosed
EP-2674477-A1 Cationic polymer stabilized microcapsule composition The Procter and Gamble Company (US) 2013-12-18 EP disclosed
EP-2553080-A1 PROCESS FOR COATING CATIONIC POLYMERS ON MICROCAPSULES The Procter & Gamble Company (US) 2013-02-06 EP disclosed
WO-2011123730-A1 PROCESS FOR COATING CATIONIC POLYMERS ON MICROCAPSULES THE PROCTER & GAMBLE COMPANY (US) 2011-10-06 WO disclosed
US-20110245141-A1 CATIONIC POLYMER STABILIZED MICROCAPSULE COMPOSITION THE PROCTER & GAMBLE COMPANY 2011-10-06 US disclosed
US-6239091-B1 REDUCING FORMATION OF SPOTS AND FILMS ON WASHED GLASSWARE BY INCORPORATING WATER SOLUBLE, CATIONIC OR AMPHOTERIC POLYMERS IN AUTOMATIC DISHWASHING PROCESS LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. 2001-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624316-B2 Treatment composition with delivery particles made from acid-treated chitosan CS, SDHB, SLC25A11 ALDH1A1 171/4885TSHR 4184/4885
US-20260071153-A1 TREATMENT COMPOSITION WITH CHITOSAN-BASED DELIVERY PARTICLES CHIT1, MUC1, EXOSC10 ALDH1A1 4498/4885TSHR 3810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.